News for June 2014

News Archive

Queen’s scientist makes major cystic fibrosis breakthrough Queen’s scientist makes major cystic fibrosis breakthrough

A Queen’s University (Belfast) doctor has played a key role in a major breakthrough to change the lives of cystic fibrosis sufferers.

OCE and OBI partner with CQDM on $3 million inter-provincial drug discovery innovation programs OCE and OBI partner with CQDM on $3 million inter-provincial drug discovery innovation programs

Ontario Centres of Excellence (OCE) and the Ontario Brain Institute (OBI) are partnering with CQDM to bring an additional $3 million to two programs dedicated to breakthrough technologies to accelerate drug discovery and development.

Redx Pharma Joins Expert International Panel on Global AMR Threat Redx Pharma Joins Expert International Panel on Global AMR Threat

Dr Neil Murray, the CEO of Liverpool-headquartered biotech Redx Pharma, will join global health experts to discuss solutions to the threat of antimicrobial resistance (AMR) at the industry-leading BIO 2014 conference in San Diego this week.

MRC Technology Sells Its Melanocortin Receptors Programme to Pfizer Inc.

Small molecules developed in collaboration with Queen Mary University of London

The view from here. June 2014 The view from here. June 2014

This month’s newsletter from Drug Discovery Today deals with the important field of peptide therapeutics

MRC brings industry and academia together in new approach to accelerate dementias research MRC brings industry and academia together in new approach to accelerate dementias research

The Medical Research Council (MRC) has launched the UK Dementias Research Platform (UKDP), a £16 million public-private partnership set up to speed up research into dementias. The collaboration aims to enable earlier detection, improved treatment and, ultimately, prevention of the disease, by looking not just at what is going wrong in the brain, but at the brain in the context of the whole body.

Owlstone Introduces UltraFAIMS for Improved Mass Spectrometry Owlstone Introduces UltraFAIMS for Improved Mass Spectrometry

A low-cost accessory for mass spectrometers that provides an additional dimension of high-speed separation by ion mobility

New study brings scientists a step closer to silencing tinnitus New study brings scientists a step closer to silencing tinnitus

New research funded by charity Action on Hearing Loss suggests that tinnitus can be eliminated by blocking signals between the ear and brain, offering hope to suffers that a cure is within reach, with prolonged exposure to loud music or working in a noisy environment often the main reasons why people are affected by the distressing condition.

Experts call for greater clarity on the prescribing and dispensing of vitamin D, urging the National Institute for Health and Care Excellence (NICE) to take action within its forthcoming public health guideline

Leading independent specialists with an interest in vitamin D today call on NICE to make clear the importance of regulated vitamin D products licensed by the MHRA (ie either prescription only medicines (POMs), pharmacy medicines (P) or general sales list (GSL) in its forthcoming public health guideline ‘Vitamin D: implementation of existing guidance to prevent deficiency’.

Haemorrhagic Fevers Can Be Caused by Body’s Antiviral Interferon Response Haemorrhagic Fevers Can Be Caused by Body’s Antiviral Interferon Response

Haemorrhagic fevers caused by Lassa, dengue and other viruses affect more than one million people annually and are often fatal, yet scientists have never understood why only some virus-infected people come down with the disease and others do not.

Sharing knowledge: The 18th International Congress of Parkinson’s Disease and Movement Disorders Sharing knowledge: The 18th International Congress of Parkinson’s Disease and Movement Disorders

Experts from all over the world will convene this month to focus on ‘emerging and experimental therapies’ in the field of movement disorders.Parkinson’s disease is a key feature, and highlighted as being of growing importance in the field of movement disorders

Royal Society of Chemistry Outlines its Conference for Lab Innovations 2014 Royal Society of Chemistry Outlines its Conference for Lab Innovations 2014

The free-to-attend Royal Society of Chemistry (RSC) conference, hosted at Lab Innovations on 5 & 6 November 2014 at Birmingham’s NEC will focus on a select group of overarching themes, including Horizon 2020 Funding, Energy, Environment, Sustainable Labs, Health & Safety, Training and Legislation.

Rapid iPad assessment paves the way for faster and more accurate decision making on cognitive safety and abuse potential of drug treatments. Rapid iPad assessment paves the way for faster and more accurate decision making on cognitive safety and abuse potential of drug treatments.

Cambridge Cognition has announced the launch of the first two iPad-tablet products on its new cloud computing Cantab Connect platform for use in clinical trials. Current practice still relies largely on pen and paper questionnaires with widespread potential for inaccuracies.